Table 3:

Treatment for immune-mediated and nutritional ataxias.

Treatment	Ataxia type	Evidence	References
IVIG	Opsoclonus myoclonus ataxia syndrome	A randomized, open label study	(de Alarcon et al., 2018)
Gluten-free diet, IVIG, steroids	Anti-DGP, anti-gliadin cerebellar ataxias	Open label	(Nanri et al., 2016)
IVIG, steroids	Anti-GAD, anti-TPO	Open label	(Nanri et al., 2016)
Thiamine	Wernicke's encephalopathy	Case reports	(Chataway and Hardman, 1995; Sinha et al., 2019)
Vitamin B12	Pernicious anemia, dietary deficiency	Case reports	(Chakrabarty et al., 2014; Stabler, 2013)

Anti-DGP: anti-deamidated gliadin peptide, anti-GAD: anti-glutamic acid decarboxylase antibody, anti-TPO: anti-thyroperoxidase antibody, IVIG: intravenous immunoglobulin